Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA.
Heart Fail Clin. 2012 Jul;8(3):331-52. doi: 10.1016/j.hfc.2012.04.006.
Dilemmas persist in the screening, assessment, and follow-up of patients with pulmonary hypertension, relating to issues of whom and how to screen, how to resolve ambiguities in the clinical classification of patients with multiple potential substrates of pulmonary vascular disease, how to interpret test results, how to integrate multiple clinical parameters into a global diagnosis, how to use ambiguous test results, how to determine disease severity and prognosis, and how to monitor patients on treatment. This article describes how to incorporate available information into the diagnostic process, and where lack of concrete data should impose caution in patient management.
在肺动脉高压患者的筛查、评估和随访中仍然存在一些难题，涉及到筛查对象和筛查方法、如何解决多种潜在肺血管疾病患者临床分类的不明确问题、如何解读检查结果、如何将多个临床参数整合到一个整体诊断中、如何利用不确定的检查结果、如何确定疾病严重程度和预后，以及如何监测治疗中的患者等问题。本文介绍了如何将现有信息纳入诊断过程中，以及在缺乏具体数据的情况下，如何谨慎管理患者。
